HbA1c for the Diagnosis of Diabetes Mellitus in a Developing Country. A Position Article

Archives of Medical Research

Volumn 41, Issue 4, 2010, Pages 302-308

  Gomez Perez, Francisco J ^a   Aguilar Salinas, Carlos A ^a   Almeda Valdes, Paloma ^a   Cuevas Ramos, Daniel ^a   Lerman Garber, Israel ^a   Rull, Juan A ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Diabetes; Diagnosis; HbA1c; Oral glucose tolerance test

Indexed keywords

HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

AGING; ANEMIA; COST; DEVELOPING COUNTRY; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; ETHICS; HUMAN; IRON DEFICIENCY; KIDNEY FAILURE; NOTE; ORAL GLUCOSE TOLERANCE TEST; RISK; SENSITIVITY ANALYSIS; SOUTH AND CENTRAL AMERICA;

DEVELOPING COUNTRIES; DIABETES MELLITUS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS;

EID: 77954637450     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2010.05.007     Document Type: Note

References (35)

1. The International Expert Committee Report on the Role of the A1C Assay in the diagnosis of Diabetes. Diabetes Care 2009, 32:1327-1334.
2. American Diabetes Association Diagnosis Criteria for Diabetes Mellitus. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2010, 33(suppl 1):S62-S69.
3. American Diabetes Association Screening for type 2 diabetes (Clinical Practice Recommendations 2004: Position Statement). Diabetes Care 2004, 27:S11-S14.
4. Vistisen D., Colagiuri S., Borch-Johnsen K. The DETECT-2 Collaboration. Bimodal distribution of glucose is not universally useful for diagnosing diabetes. Diabetes Care 2009, 32:397-403.
5. Bennett A.L., Guop M., Dharmage S.C. HbA1C as a screening tool for detection of type 2 diabetes: a systematic review. Diabet Med 2007, 24:333-343.
6. Sabanayagam C., Liew G., Tai E.S., et al. Relationship between glycated haemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes?. Diabetologia 2009, 52:1279-1289.
7. Selvin E., Steffes M.W., Zhu H., et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010, 362:800-811.
8. The DECODE Study Group Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and non-cardiovascular diseases. Diabetes Care 2003, 26:688-696.
9. Goldstein D.E., Little R.R., Lorenz R.A., et al. Global harmonization of hemoglobin A1c. Clin Chem 2005, 51:681-683.
10. Lenters-Westra E., Slingerland R.J. Six out of eight hemoglobin A1c point-of care instruments do not meet the generally accepted analytical performance criteria. Clin Chem 2010, 56:44-52.
11. Amquist H., Wallensteen M., Jeppsson J.O. Standardization of long-term glucose measurements established. Lakartidningen 1997, 50:4789-4790.
12. Peters A.L., Davidson M.B., Schigrer D.L., et al. A clinical approach for the diagnosis of diabetes mellitus. An analysis using glycosylated hemoglobin levels. JAMA 1996, 276:1246-1252.
13. Faerch A., Borch-Johnsen K., Vaag A., et al. Sex differences in glucose levels: a consequence of physiology or methodological convenience? The Inter99 study. Diabetologia 2010, 53:858-865.
14. Shima K., Endo J., Oimoni Y., et al. A report of the committee on an inter-laboratory standardization of HbA1C determination. The Japan Diabetes Society. J Jpn Diabetes Soc 1994, 37:855-864.
15. García-Alcalá H., Ruiz-Argüelles A., Cedillo-Carvallo B. Effect of the method to measure levels of glycated hemoglobin on individual clinical decisions comparison of an immunoassay with high-performance liquid chromatography. Am J Clin Pathol 2009, 132:332-335.
16. Ezenwaka C., Jones-LeCointe A., Nwagbara E., et al. Anaemia and kidney dysfunction in Caribbean type 2 diabetic patients. Cardiovasc Diabetol 2008, 7:25-31.
17. Buell C., Kermah D., Davidson M.B. Utility of A1C for diabetes screening in the 1999 2004 NHANES population. Diabetes Care 2007, 30:2233-2235.
18. Ravi Kumar P, Bhansali A, Ravikiran M, et al. Utility of glycated hemoglobin in diagnosing type 2 diabetes mellitus: a community-based study. J Clin Endocrinol Metab. Published ahead of print April 6, 2010 (doi:10.1210/jc.2009-2433).
19. Saudek C.D., Herman W.H., Sacks D.B., et al. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab 2008, 93:2447-2453.
20. Herman W.H., Fajans S.S. Hemoglobin A1c for the diagnosis of diabetes: practical considerations. Pol Arch Med Wewn 2010, 120:37-41.
21. Kramer C.K., Araneta M.R., Barrett-Connor E. A1C and diabetes diagnosis: The Rancho Bernardo Study. Diabetes Care 2010, 33:101-103.
22. Carson A., Reynolds K., Fonseca V., et al. Comparison of A1C and fasting glucose criteria to diagnose diabetes among U.S. adults. Diabetes Care 2010, 33:95-97.
23. Lu X., Walker K., O'Dea K., et al. A1C for screening and diagnosis of type 2 diabetes in routine clinical practice. Diabetes Care 2010, 33:817-819.
24. Herman W.H., Dungan K.M., Wolffenbuttel B.H.R., et al. Racial and ethnic differences in mean glucose, hemoglobin A1c, and 1,5 anhydroglucitol in over 2000 patients with type 2 diabetes. J Clin Endocrinol Metab 2009, 94:1689-1694.
25. Christensen D.L., Witte D.R., Kduka L., et al. Moving to an A1c-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups. Diabetes Care 2010, 33:580-582.
26. Anand S.S., Razak F., Vuksan V., et al. Diagnostic strategies to detect glucose intolerance in a multiethnic population. Diabetes Care 2003, 26. 290-229.
27. Cowie C., Rust K., Byrd-Holt D., et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Diabetes Care 2010, 33:562-568.
28. Herman W.H., Ma Y., Uwaifo G., et al. Diabetes Prevention Program Research Group Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care 2007, 30:2453-2457.
29. Kim C., McKeever K., Herman W.H., et al. Association between iron deficiency spherocytosis and HbA1C levels among adults without diabetes in the National Health and Nutrition Examination Survey, 1999-2006. Diabetes Care 2010, 33:780-785.
30. El-Agouza I., Abu S.A., Syrdah M. The effect of iron-deficiency anaemia on the glycosylated hemoglobin subtypes: possible consequences for clinical diagnosis. Clin Lab Haematol 2002, 24:285-289.
31. Pani L.N., Korenda L., Meigs J.M., et al. Effect of aging on A1C levels in individuals without diabetes. Diabetes Care 2008, 31:1991-1996.
32. Krovesdy C.P., Sharma K., Kalantar-Zadeh K. Glycemic control in diabetic CKD patients: where do we stand?. Am J Kidney Dis 2008, 52:766-777.
33. Gomez-Perez F.J., Valles-Sanchez V.E., Lopez-Alvarenga J.C., et al. Vitamin E modifies neither fructosamine nor HbA1c levels in poorly controlled diabetes. Rev Invest Clin 1996, 48:421-424.
34. Gomez-Perez F.J., Aguilar-Salinas C.A., López-Alvarenga J.C., et al. Lack of agreement between the World Health Organization category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose. Diabetes Care 1998, 21:1886-1888.
35. Ko G.T.C., Chan J.C.N., Yeung V.T.F., et al. Combined use of fasting plasma glucose concentration and HbA1C or fructosamine predicts the likelihood of having diabetes in high risk subjects. Diabetes Care 1998, 21:1221-1225.